Cited by 4,760Diabetes, Cardiovascular Risks, and LipoproteinsCardiovascular Function and Risk FactorsCardiovascular Health and Risk Factors

The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.

Cardiovascular Morbidity and Mortality Associated With the Metabolic Syndrome

Isomaa, Bo, Almgren, Peter, Tuomi, Tiinamaija, Forsén, Björn, Lahti, Kaj, Nissén, Michael, Taskinen, Marja-Riitta, Groop, Leif·2001·Diabetes Care

DOI 10.2337/diacare.24.4.683

Open this paper in CoChat — free account

Abstract

OBJECTIVE—To estimate the prevalence of and the cardiovascular risk associated with the metabolic syndrome using the new definition proposed by the World Health Organization (WHO). RESEARCH DESIGN AND METHODS—A total of 4,483 subjects aged 35–70 years participating in a large family study of type 2 diabetes in Finland and Sweden (the Botnia study) were included in the analysis of cardiovascular risk associated with the metabolic syndrome. In subjects who had type 2 diabetes (n = 1,697), impaired fasting glucose (IFG)/impaired glucose tolerance (IGT) (n = 798), or insulin-resistance with normal glucose tolerance (NGT) (n = 1,988), the metabolic syndrome was defined as presence of at least two of the following risk factors: obesity, hypertension, dyslipidemia, or microalbuminuria. Cardiovascular mortality was assessed in 3,606 subjects with a median follow-up of 6.9 years. RESULTS—In women and men, respectively, the metabolic syndrome was seen in 10 and 15% of subjects with NGT, 42 and 64% of those with IFG/IGT, and 78 and 84% of those with type 2 diabetes. The risk for coronary heart disease and stroke was increased threefold in subjects with the syndrome (P < 0.001). Cardiovascular mortality was markedly increased in subjects with the metabolic syndrome (12.0 vs. 2.2%, P < 0.001). Of the individual components of the metabolic syndrome, microalbuminuria conferred the strongest risk of cardiovascular death (RR 2.80; P = 0.002). CONCLUSIONS—The WHO definition of the metabolic syndrome identifies subjects with increased cardiovascular morbidity and mortality and offers a tool for comparison of results from different studies.

Integrity signals

Registry

Crossref · 10.2337/diacare.24.4.683

Cites

39 of 39 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge
Friedewald, W. T., Levy, R. I., & Fredrickson, D. S. (1972) · Clinical Chemistry · doi:10.1093/clinchem/18.6.499 · Cited by 32,423
Role of Insulin Resistance in Human Disease
Reaven, G. M. (1988) · Diabetes · doi:10.2337/diab.37.12.1595 · Cited by 12,154
The glucose fatty-acid cycle. Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus
Randle, P. J., Garland, P. B., Hales, C. N., & Newsholme, E. A. (1963) · The Lancet · doi:10.1016/s0140-6736(63)91500-9 · Cited by 5,093
Insulin Resistance: A Multifaceted Syndrome Responsible for NIDDM, Obesity, Hypertension, Dyslipidemia, and Atherosclerotic Cardiovascular Disease
DeFronzo, R. A., & Ferrannini, E. (1991) · Diabetes Care · doi:10.2337/diacare.14.3.173 · Cited by 4,555
Cardiovascular Survey Methods.
Rose, G., & Blackburn, H. (1968) · Annals of Internal Medicine · doi:10.7326/0003-4819-69-6-1335_2 · Cited by 3,090
Myocardial infarction and coronary deaths in the World Health Organization MONICA Project. Registration procedures, event rates, and case-fatality rates in 38 populations from 21 countries in four continents.
Tunstall-Pedoe, H., Kuulasmaa, K., Amouyel, P., Arveiler, D., Rajakangas, A.-M., & Pająk, A. (1994) · Circulation · doi:10.1161/01.cir.90.1.583 · Cited by 2,260
Comment on the provisional report from the WHO consultation
(1999) · Diabetic Medicine · doi:10.1046/j.1464-5491.1999.00059.x · Cited by 1,820
Role of Fatty Acids in the Pathogenesis of Insulin Resistance and NIDDM
Boden, G. (1997) · Diabetes · doi:10.2337/diab.46.1.3 · Cited by 1,728
The Deadly Quartet
Kaplan, N. M. (1989) · Archives of Internal Medicine · doi:10.1001/archinte.149.7.1514 · Cited by 1,672
Hyperinsulinemia. A link between hypertension obesity and glucose intolerance.
Modan, M., Halkin, H., Almog, S., Lusky, A., Eshkol, A., Shefi, M., Shitrit, A., & Fuchs, Z. (1985) · Journal of Clinical Investigation · doi:10.1172/jci111776 · Cited by 1,465

Show all 36 references

Research works printed but not linked: 2

Descovich GC, Benassi B, Cancelli V, D’Addato S, De Simone, Dormi A: An epidemic view of the plurimetabolic syndrome. In Diabetes, Obesity and Hyperlipidemias. V. The Plurimetabolic Syndrome Crepaleli G, Tiengo A, Manzato E, Eds. Amsterdam, Netherlands, Elsevier Science, 1993, p. 31–39
Bouchard C, Perusse L: Genetics of causes and manifestations of the metabolic syndrome. In Diabetes, obesity and hyperlipidemia: V. The plurimetabolic syndrome Crepaldi G, Tiengo A, Manzato E, Eds., Amsterdam, Elsevier Science, 1993, p. 67–74

Sorted by citations

Items 701–800 of 1,022

Reference levels of blood mercury and association with metabolic syndrome in Korean adults
Eom, S., Choi, S., Ahn, S.-J., Kim, D.-K., Kim, D., Lim, J.-A., Choi, B., Shin, H.-J., Yun, S.-W., Yoon, H., et al. (2013) · International Archives of Occupational and Environmental Health · doi:10.1007/s00420-013-0891-8 · Cited by 94
Association Between Quantity of Liver Fat and Cardiovascular Risk in Patients With Nonalcoholic Fatty Liver Disease Independent of Nonalcoholic Steatohepatitis
Arulanandan, A., Ang, B., Bettencourt, R., Hooker, J. C., Behling, C. A., Lin, G., Valasek, M. A., Ix, J. H., Schnabl, B., Sirlin, C. B., et al. (2015) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2015.01.027 · Cited by 94
Cardio-ankle vascular index predicts for the incidence of cardiovascular events in obese patients: A multicenter prospective cohort study (Japan Obesity and Metabolic Syndrome Study: JOMS)
Satoh‐Asahara, N., Kotani, K., Yamakage, H., Yamada, T., Araki, R., Okajima, T., Adachi, M., Oishi, M., & Shimatsu, A. (2015) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2015.08.003 · Cited by 95
Quality of life among postmenopausal Ecuadorian women participating in a metabolic syndrome screening program
Chedraui, P. A., Hidalgo, L., Chavez, D., Morocho, N., Alvarado, M., & Huc, A. (2006) · Maturitas · doi:10.1016/j.maturitas.2006.05.008 · Cited by 94
Genotype, obesity and cardiovascular disease – has technical and social advancement outstripped evolution?
Zimmet, P., & Thomas, C. (2003) · Journal of Internal Medicine · doi:10.1046/j.1365-2796.2003.01170.x · Cited by 93
Pharmacological treatment and therapeutic perspectives of metabolic syndrome
Lim, S. K., & Eckel, R. H. (2014) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-014-9298-4 · Cited by 98
Hypertension, insulin resistance, and the metabolic syndrome
Natali, A., & Ferrannini, E. (2004) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2004.03.007 · Cited by 95
High prevalence of the metabolic syndrome among Northern Jordanians
Khader, Y. S., Batieha, A. M., El-Khateeb, M. S., Alshaikh, A. A., & Ajlouni, K. M. (2007) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2005.11.003 · Cited by 92
Mental slowness and executive dysfunctions in patients with metabolic syndrome.
Segura, B., Jurado, M., Freixenet, N., Albuin, C., Muniesa, J., & Junqué, C. (2009) · Neuroscience Letters · doi:10.1016/j.neulet.2009.06.071 · Cited by 95
Metabolic syndrome, its preeminent clusters, incident coronary heart disease and all‐cause mortality – results of prospective analysis for the Atherosclerosis Risk in Communities study
Hong, Y., Jin, X., Mo, J. M. Y., Lin, H. ‐., Duan, Y., Pu, M., Wolbrette, D. L., & Liao, D. (2007) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2007.01781.x · Cited by 93
Treatment of insulin resistance in diabetes mellitus
Lebovitz, H. E., & Banerji, M. A. (2004) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2004.02.051 · Cited by 96
Genotype-by-Diet Interactions Drive Metabolic Phenotype Variation inDrosophila melanogaster
Reed, L. K., Williams, S., Springston, M., Brown, J., Freeman, K., DESROCHES, C. E., Sokolowski, M. B., & Gibson, G. C. (2010) · Genetics · doi:10.1534/genetics.109.113571 · Cited by 94
The relation of insulin resistance syndromes to risk of cardiovascular disease.
Nesto, R. W. (2003) · PubMed · Cited by 93
Oral, transdermal and vaginal combined contraceptives induce an increase in markers of chronic inflammation and impair insulin sensitivity in young healthy normal-weight women: a randomized study
Piltonen, T., Puurunen, J., Hedberg, P., Ruokonen, A., Mutt, S. J., Herzig, K. H., Nissinen, A., Morin-Papunen, L., & Tapanainen, J. S. (2012) · Human Reproduction · doi:10.1093/humrep/des225 · Cited by 94
Leptin in Atherosclerosis: Focus on Macrophages, Endothelial and Smooth Muscle Cells
Raman, P., & Khanal, S. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22115446 · Cited by 99
Mechanisms Linking Nonalcoholic Fatty Liver Disease with Coronary Artery Disease
Nseir, W., Shalata, A., Marmor, A. T., & Assy, N. (2011) · Digestive Diseases and Sciences · doi:10.1007/s10620-011-1767-y · Cited by 93
Hyperelongated biglycan: the surreptitious initiator of atherosclerosis
Little, P. J., Osman, N., & O’Brien, K. D. (2008) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e32830dd7c4 · Cited by 92
A comparison of the NCEP-ATPIII, IDF and AHA/NHLBI metabolic syndrome definitions with relation to early carotid atherosclerosis in subjects with hypercholesterolemia or at risk of CVD: Evidence for sex-specific differences
Skilton, M. R., Moulin, P., Sérusclat, A., Nony, P., & Bonnet, F. (2006) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2006.02.019 · Cited by 92
Control of diabetes and cardiovascular risk factors in patients with type 2 diabetes in primary care. The gap between guidelines and reality in Spain
Orozco‐Beltrán, D., Gil-Guillén, V. F., Quirce, F., Navarro-Perez, J., Pineda, M., de la Cámara, A. G., Pita, S., Díez‐Espino, J., Mateos, J., Merino, J., et al. (2007) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2007.01367.x · Cited by 93
Cohort Profile: The Metabolic syndrome and Cancer project (Me-Can)
Stocks, T., Borena, W., Strohmaier, S., Bjørge, T., Manjer, J., Engeland, A., Johansen, D., Selmer, R. M., Hallmans, G., Rapp, K., et al. (2009) · International Journal of Epidemiology · doi:10.1093/ije/dyp186 · Cited by 92
Impact of weight loss on waist circumference and the components of the metabolic syndrome
Rothberg, A. E., McEwen, L. N., Kraftson, A. T., Ajluni, N., Fowler, C. E., Nay, C. K., Miller, N. M., Burant, C. F., & Herman, W. H. (2017) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2016-000341 · Cited by 92
Use of fenofibrate on cardiovascular outcomes in statin users with metabolic syndrome: propensity matched cohort study
Kim, N. H., Han, K. H., Choi, J., Lee, J., & Kim, S. G. (2019) · BMJ · doi:10.1136/bmj.l5125 · Cited by 95
Association between Metabolic Syndrome and Risk of Stroke: A Meta-Analysis of Cohort Studies
Li, W., Ma, D., Liu, M., Liu, H., Feng, S., Hao, Z., Wu, B., & Zhang, S. (2008) · Cerebrovascular Diseases · doi:10.1159/000131672 · Cited by 91
Myocardial and Vascular Dysfunction and Exercise Capacity in the Metabolic Syndrome
Wong, C. Y., O'Moore‐Sullivan, T. M., Fang, Z. Y., Haluska, B. A., Leano, R., & Marwick, T. H. (2005) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2005.07.091 · Cited by 90
Number of Children and Risk of Metabolic Syndrome in Women
Cohen, A., Pieper, C. F., Brown, A. J., & Bastian, L. A. (2006) · Journal of Women s Health · doi:10.1089/jwh.2006.15.763 · Cited by 91
Suppressor of cytokine signaling-3 (SOCS-3) and a deficit of serine/threonine (Ser/Thr) phosphoproteins involved in leptin transduction mediate the effect of fructose on rat liver lipid metabolism
Vilà, L., Roglans, N., Alegret, M., Sánchez, R. M., Vázquez‐Carrera, M., & Laguna, J. C. (2008) · Hepatology · doi:10.1002/hep.22523 · Cited by 92
Association of Physical Activity and Renal Function in Subjects With and Without Metabolic Syndrome: A Review of the Third National Health and Nutrition Examination Survey (NHANES III)
Finkelstein, J., Joshi, A., & Hise, M. K. (2006) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2006.05.013 · Cited by 91
Cost-Effective Screening for the Metabolic Syndrome in Patients Treated With Second-Generation Antipsychotic Medications
Straker, D., Correll, C. U., Kramer‐Ginsberg, E., Abdulhamid, N., Koshy, F., Rubens, E. O., Saint-Vil, R., Kane, J. M., & Manu, P. (2005) · American Journal of Psychiatry · doi:10.1176/appi.ajp.162.6.1217 · Cited by 89
Differential effect of subcutaneous abdominal and visceral adipose tissue on cardiometabolic risk
Sam, S. (2018) · Hormone Molecular Biology and Clinical Investigation · doi:10.1515/hmbci-2018-0014 · Cited by 98
Multiple Hits in Acute Pancreatitis: Components of Metabolic Syndrome Synergize Each Other’s Deteriorating Effects
Szentesi, A., Párniczky, A., Vincze, Á., Bajor, J., Gódi, S., Sarlós, P., Gede, N., Izbéki, F., Halász, A., Márta, K., et al. (2019) · Frontiers in Physiology · doi:10.3389/fphys.2019.01202 · Cited by 93
Prevalence of vascular disease in metabolic syndrome using three proposed definitions
Athyros, V. G., Ganotakis, E. S., Elisaf, M., Liberopoulos, E. N., Goudevenos, I. A., & Karagiannis, A. I. (2006) · International Journal of Cardiology · doi:10.1016/j.ijcard.2006.04.078 · Cited by 90
Weight fluctuations and risk for metabolic syndrome in an adult cohort
Vergnaud, A. C., Bertrais, S., Oppert, J., Maillard-Teyssier, L., Galan, P., Herçberg, S., & Czernichow, S. (2007) · International Journal of Obesity · doi:10.1038/sj.ijo.0803739 · Cited by 90
Obesity and metabolic changes are common in young childhood brain tumor survivors
Pietilä, S., Mäkipernaa, A., Sievänen, H. T., Koivisto, A., Wigren, T., & Lenko, H. L. (2009) · Pediatric Blood & Cancer · doi:10.1002/pbc.21936 · Cited by 93
Circulating adiponectin levels, body composition and obesity-related variables in Prader–Willi syndrome: comparison with obese subjects
Kennedy, L., Bittel, D. C., Kibiryeva, N., Kalra, S. P., Torto, R., & Butler, M. G. (2005) · International Journal of Obesity · doi:10.1038/sj.ijo.0803115 · Cited by 90
Cytokine and growth factor profiling in patients with the metabolic syndrome
Mirhafez, S. R., Pasdar, A., Avan, A., Esmaily, H., Moezzi, A., Mohebati, M., Meshkat, Z., Mehrad‐Majd, H., Eslami, S., Rahimi, H. R., et al. (2015) · British Journal Of Nutrition · doi:10.1017/s0007114515001038 · Cited by 90
Effects of myo-inositol supplementation in postmenopausal women with metabolic syndrome: a perspective, randomized, placebo-controlled study
Giordano, D., Corrado, F., Santamaria, A., Quattrone, S., Pintaudi, B., Di Benedetto, A., & D'Anna, R. (2011) · Menopause · doi:10.1097/gme.0b013e3181e8e1b1 · Cited by 89
Circulating leptin, resistin, adiponectin, visfatin, adipsin and ghrelin levels and insulin resistance in postmenopausal women with and without the metabolic syndrome
Chedraui, P. A., Pérez-López, F. R., Escobar, G. S., Palla, G., Guevara, M. M. M., Cecchi, E., Genazzani, A. R., & Simoncini, T. (2014) · Maturitas · doi:10.1016/j.maturitas.2014.06.008 · Cited by 91
Complications associated with laparoscopic sleeve gastrectomy – a review
Woźniewska, P., Diemieszczyk, I., & Hady, H. R. (2021) · Gastroenterology Review · doi:10.5114/pg.2021.104733 · Cited by 89
Does omega-3 PUFAs supplementation improve metabolic syndrome and related cardiovascular diseases? A systematic review and meta-analysis of randomized controlled trials
Wang, Y., Wang, Y., Shehzad, Q., Su, Y., Xu, L., Yu, L., Zeng, W., Fang, Z., Wu, G., Wei, W., et al. (2023) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2023.2212817 · Cited by 91
Prevalence of Metabolic Syndrome in COPD Patients and Its Consequences
Breyer, M., Spruit, M. A., Hanson, C., Franssen, F. M. E., Vanfleteren, L. E. G. W., Groenen, M. T. J., Bruijnzeel, P. L. B., Wouters, E. F. �., & Rutten, E. P. A. (2014) · PLoS ONE · doi:10.1371/journal.pone.0098013 · Cited by 89
The Metabolic Syndrome: A Concept Hard to Define
Aguilar-Salinas, C. A., Rojas, R., Gomez-Perez, F. J., Mehta, R., Franco, A., Oláiz, G., & Rull, J. A. (2005) · Archives of Medical Research · doi:10.1016/j.arcmed.2004.12.003 · Cited by 94
Neighborhood Disadvantage, Neighborhood Safety and Cardiometabolic Risk Factors in African Americans: Biosocial Associations in the Jackson Heart Study
Clark, C. R., Ommerborn, M. J., Hickson, D. A., Grooms, K. N., Sims, M., Taylor, H. A., & Albert, M. A. (2013) · PLoS ONE · doi:10.1371/journal.pone.0063254 · Cited by 90
The Glucocorticoid Receptor Gene and Its Association to Metabolic Syndrome
Rosmond, R. (2002) · Obesity Research · doi:10.1038/oby.2002.146 · Cited by 91
Metabolic syndrome as a risk factor for coronary heart disease and stroke: An 11-year prospective cohort in Taiwan community
Chien, K., Hsu, H., Sung, F., Su, T., Chen, M.-F., & Lee, Y. (2006) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2006.07.033 · Cited by 88
Metabolic syndrome increases all‐cause and vascular mortality: the Hong Kong Cardiovascular Risk Factor Study
Thomas, G. N., Schooling, C. M., McGhee, S. M., Ho, S. Y., Cheung, B. M. Y., Wat, N. M. S., Janus, E. D., Lam, K. S. L., & Lam, T. H. (2007) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2007.02798.x · Cited by 89
The Hypertension–Diabetes Continuum
Cheung, B. M. Y. (2010) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0b013e3181d26430 · Cited by 89
P66Shc signals to age
Trinei, M., Berniakovich, I., Beltrami, E., Migliaccio, E., Fassina, A., Pelicci, P. G., & Giorgio, M. (2009) · Aging · doi:10.18632/aging.100057 · Cited by 88
Impact of obesity on renal transplant outcomes
Armstrong, K. A., Campbell, S. B., Hawley, C. M., Johnson, D. W., & Isbel, N. M. (2005) · Nephrology · doi:10.1111/j.1440-1797.2005.00406.x · Cited by 88
20-HETE and F2-isoprostanes in the metabolic syndrome: the effect of weight reduction
Tsai, I.-J., Croft, K. D., Mori, T. A., Falck, J. R., Beilin, L. J., Puddey, I. B., & Barden, A. E. (2008) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2008.10.028 · Cited by 88
The Stability of Metabolic Syndrome in Children and Adolescents
Gustafson, J. K., Yanoff, L. B., Easter, B. D., Brady, S. M., Keil, M. F., Roberts, M. D., Sebring, N. G., Han, J. C., Yanovski, S. Z., Hubbard, V. S., et al. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-2665 · Cited by 88
The islet autoantibody titres: their clinical relevance in latent autoimmune diabetes in adults (LADA) and the classification of diabetes mellitus
van Deutekom, A. W., Heine, R. J., & Şimşek, S. (2007) · Diabetic Medicine · doi:10.1111/j.1464-5491.2007.02316.x · Cited by 87
METFORMIN, ARTERIAL FUNCTION, INTIMA–MEDIA THICKNESS AND NITROXIDATION IN METABOLIC SYNDROME: THE MEFISTO STUDY
Meaney, E., Vela, A., Samaniego, V., Meaney, A., Asbún, J., Zempoalteca, J. C., Elisa, Z. N., Emma, M. N., Guzman, M., Hicks, J. J., et al. (2008) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.2008.04920.x · Cited by 89
Transplant-Associated Hyperglycemia
Crutchlow, M. F., & Bloom, R. D. (2007) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.03671106 · Cited by 89
Posttraumatic stress disorder is a risk factor for metabolic syndrome in an impoverished urban population
Weiss, T., Skelton, K., Phifer, J., Jovanovic, T., Gillespie, C. F., Smith, A., Umpierrez, G., Bradley, B., & Ressler, K. J. (2011) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2011.01.002 · Cited by 87
Ameliorative effect of myricetin on insulin resistance in mice fed a high-fat, high-sucrose diet
Choi, H., Kang, M., Lee, S., & Kim, J.-I. (2014) · Nutrition Research and Practice · doi:10.4162/nrp.2014.8.5.544 · Cited by 90
Critério de obesidade central em população brasileira: impacto sobre a síndrome metabólica
Barbosa, P. J. B., Lessa, Í., Filho, N. D. A., Magalhães, L. B. N. C., & Araújo, J. (2006) · Arquivos Brasileiros de Cardiologia · doi:10.1590/s0066-782x2006001700003 · Cited by 87
Prevalence and Management of Dyslipidemia in Korea: Korea National Health and Nutrition Examination Survey during 1998 to 2010
Roh, E., Ko, S., Kwon, H., Kim, N. H., Kim, J. H., Kim, C. S., Song, K., Won, J. C., Kim, D. J., Choi, S. H., et al. (2013) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2013.37.6.433 · Cited by 90
Changes in the Characteristics of Metabolic Syndrome in Korea Over the Period 1998–2001 as Determined by Korean National Health and Nutrition Examination Surveys
Lim, S. K., Park, K. S., Lee, H. K., & Cho, S. (2005) · Diabetes Care · doi:10.2337/diacare.28.7.1810 · Cited by 87
Metabolic Syndrome and Subclinical Atherosclerosis in Patients Infected with HIV
Mangili, A., Jacobson, D. L., Gerrior, J., Polak, J. F., Gorbach, S. L., & Wanke, C. A. (2007) · Clinical Infectious Diseases · doi:10.1086/516616 · Cited by 87
Introduction to the metabolic syndrome
Alberti, K. G. M. M. (2005) · European Heart Journal Supplements · doi:10.1093/eurheartj/sui021 · Cited by 85
Insulin Generates Free Radicals by an NAD(P)H, Phosphatidylinositol 3′-Kinase-Dependent Mechanism in Human Skin Fibroblasts Ex Vivo
Ceolotto, G., Bevilacqua, M., Papparella, I., Baritono, E., Franco, L., Corvaja, C., Mazzoni, M., Semplicini, A., & Avogaro, A. (2004) · Diabetes · doi:10.2337/diabetes.53.5.1344 · Cited by 87
Prevalence and incidence of the metabolic syndrome in the European Lacidipine Study on Atherosclerosis (ELSA) and its relation with carotid intima–media thickness
Zanchetti, A., Hennig, M., Baurecht, H., Tang, R., Cuspidi, C., Carugo, S., & Mancia, G. (2007) · Journal of Hypertension · doi:10.1097/hjh.0b013e3282f063d5 · Cited by 86
The metabolic syndrome among postmenopausal women in Ecuador
Hidalgo, L., Chedraui, P. A., Morocho, N., Alvarado, M., Chavez, D., & Huc, A. (2006) · Gynecological Endocrinology · doi:10.1080/09513590600890272 · Cited by 86
The Prevalence of Metabolic Syndrome Among US Women of Childbearing Age
Ramos, R. G., & Olden, K. (2008) · American Journal of Public Health · doi:10.2105/ajph.2007.120055 · Cited by 86
Impact of 4 different definitions used for the assessment of the prevalence of the Metabolic Syndrome in primary healthcare:The German Metabolic and Cardiovascular Risk Project (GEMCAS)
Moebus, S., Hanisch, J. U., Aidelsburger, P., Bramlage, P., Wasem, J., & Jöckel, K. (2007) · Cardiovascular Diabetology · doi:10.1186/1475-2840-6-22 · Cited by 86
Lifetime Alcohol Drinking Pattern is Related to the Prevalence of Metabolic Syndrome. The Western New York Health Study (WNYHS)
Fan, A. Z., Russell, M., Dorn, J. M., Freudenheim, J. L., Nochajski, T. H., Hovey, K. M., & Trevisan, M. (2006) · European Journal of Epidemiology · doi:10.1007/s10654-005-5457-y · Cited by 87
Body mass index and ovarian function are associated with endocrine and metabolic abnormalities in women with hyperandrogenic syndrome
Cupisti, S., Kajaia, N., Dittrich, R., Duezenli, H., Beckmann, M. W., & Mueller, A. (2008) · European Journal of Endocrinology · doi:10.1530/eje-07-0515 · Cited by 86
The prevalence of the metabolic syndrome is increased in patients with GH deficiency, irrespective of long-term substitution with recombinant human GH
van der Klaauw, A. A., Biermasz, N. R., Feskens, E. J. M., Bos, M. B., Smit, J. W. A., Roelfsema, F., Corssmit, E. P. M., Pijl, H., Romijn, J. A., & Pereira, A. M. (2007) · European Journal of Endocrinology · doi:10.1530/eje-06-0699 · Cited by 86
Lipids and CVD management: towards a global consensus
Ballantyne, C. M., Arroll, B., & Shepherd, J. (2005) · European Heart Journal · doi:10.1093/eurheartj/ehi373 · Cited by 86
The metabolic syndrome
Nugent, A. P. (2004) · Nutrition Bulletin · doi:10.1111/j.1467-3010.2004.00403.x · Cited by 85
Epidemiology of the insulin resistance syndrome
Meigs, J. B. (2003) · Current Diabetes Reports · doi:10.1007/s11892-003-0057-2 · Cited by 87
Prevalence of metabolic syndrome and associated risk factors among Turkish adults: Trabzon MetS study
Erem, C., Hacıhasanoğlu, A., Değer, O., Topbaş, M., Hosver, I., Ersöz, H. Ö., & Çan, G. (2008) · Endocrine · doi:10.1007/s12020-008-9044-3 · Cited by 86
Psychosocial Risk Factors and the Metabolic Syndrome in Elderly Persons: Findings From the Health, Aging and Body Composition Study
Vogelzangs, N., Beekman, A. T. F., Kritchevsky, S. B., Newman, A. B., Pahor, M., Yaffe, K., Rubin, S. M., Harris, T. B., Satterfield, S., Simonsick, E. M., et al. (2007) · The Journals of Gerontology Series A · doi:10.1093/gerona/62.5.563 · Cited by 85
Resolution of Diabetes Mellitus and Metabolic Syndrome following Roux-en-Y Gastric Bypass and a Variant of Biliopancreatic Diversion in Patients with Morbid Obesity
Alexandrides, T. K., Skroubis, G., & Kalfarentzos, F. E. (2007) · Obesity Surgery · doi:10.1007/s11695-007-9044-z · Cited by 85
The metabolic syndrome in type 1 diabetes: does it exist and does it matter?
McGill, M. J., Molyneaux, L. M., Twigg, S. M., & Yue, D. K. (2008) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2006.10.005 · Cited by 85
The association between cardiorespiratory fitness and C-reactive protein in subjects with the metabolic syndrome
Aronson, D., Sella, R., Sheikh-Ahmad, M., Kerner, A., Avizohar, O., Rispler, S., Bartha, P., Markiewicz, W., Levy, Y., & Brook, G. J. (2004) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2004.08.030 · Cited by 84
Prevalence of Metabolic Syndrome by different definitions, and its association with type 2 diabetes, pre-diabetes, and cardiovascular disease risk in Brazil
Moreira, N. C. D. V., Hussain, A., Bhowmik, B., Mdala, I., Siddiquee, T., Fernandes, V. O., Montenegro, R. M., & Meyer, H. E. (2020) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2020.05.043 · Cited by 84
Effects of 1-year yoga on cardiovascular risk factors in middle-aged and older adults with metabolic syndrome: a randomized trial
Siu, P. M., Yu, A. P., Benzie, I. F. F., & Woo, J. (2015) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-015-0034-3 · Cited by 84
Restorative Yoga in Adults with Metabolic Syndrome: A Randomized, Controlled Pilot Trial
Cohen, B. E., Chang, A. A., Grady, D. G., & Kanaya, A. M. (2008) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2008.0016 · Cited by 85
A constellation of complications:The metabolic syndrome
Grundy, S. M. (2005) · Clinical cornerstone · doi:10.1016/s1098-3597(05)80066-3 · Cited by 84
Phosphatidylinositol-3,4,5-Triphosphate and Cellular Signaling: Implications for Obesity and Diabetes
Manna, P., & Jain, S. K. (2015) · Cellular Physiology and Biochemistry · doi:10.1159/000373949 · Cited by 87
Prevalence of Metabolic Syndrome Among HIV Patients
Gazzaruso, C., Sacchi, P., Garzaniti, A., Fratino, P., Bruno, R., & Filice, G. (2002) · Diabetes Care · doi:10.2337/diacare.25.7.1253 · Cited by 84
Metabolic syndrome in Japanese diagnosed with visceral fat measurement by computed tomography
Miyawaki, T., Hirata, M., Moriyama, K., Sasaki, Y., Hideshi, A. O. N. O., SAITO, N., & Nakao, K. (2005) · Proceedings of the Japan Academy Series B · doi:10.2183/pjab.81.471 · Cited by 84
High-Density Lipoprotein Cholesterol and Coronary Heart Disease
Young, C. E., Karas, R. H., & Kuvin, J. T. (2004) · Cardiology in Review · doi:10.1097/01.crd.0000097140.29929.8a · Cited by 84
Metabolic syndrome and cardiovascular disease following hematopoietic cell transplantation: screening and preventive practice recommendations from CIBMTR and EBMT
DeFilipp, Z. M., Duarte, R. F., Snowden, J. A., Majhail, N. S., Greenfield, D., López‐Miranda, J., Arat, M., Baker, K. S., Burns, L. J., Duncan, C., et al. (2016) · Bone Marrow Transplantation · doi:10.1038/bmt.2016.203 · Cited by 84
Diseases Associated with Childhood Obesity
Choudhary, A. K., Donnelly, L. F., Racadio, J. M., & Strife, J. L. (2007) · American Journal of Roentgenology · doi:10.2214/ajr.06.0651 · Cited by 86
Epigenetic age acceleration and metabolic syndrome in the coronary artery risk development in young adults study
Nannini, D. R., Joyce, B. T., Zheng, Y., Gao, T., Liu, L., Yoon, G., Huan, T., Ma, J., Jacobs, D. R., Wilkins, J. T., et al. (2019) · Clinical Epigenetics · doi:10.1186/s13148-019-0767-1 · Cited by 85
Late adverse effects and quality of life in survivors of testicular germ cell tumour
Chovanec, M., Lauritsen, J., Bandak, M., Oing, C., Kier, G. G., Kreiberg, M., Rosenvilde, J. J., Wagner, T., Bokemeyer, C., & Daugaard, G. (2021) · Nature Reviews Urology · doi:10.1038/s41585-021-00440-w · Cited by 83
Prevalence of metabolic syndrome among patients with schizophrenia in Japan
Sugawara, N., Yasui‐Furukori, N., Sato, Y., Umeda, T., Kishida, I., Yamashita, H., Saito, M., Furukori, H., Nakagami, T., Hatakeyama, M., et al. (2010) · Schizophrenia Research · doi:10.1016/j.schres.2010.08.030 · Cited by 83
Reduction in obesity and coronary risk factors after high caloric exercise training in overweight coronary patients
Savage, P. D., Brochu, M., Poehlman, É. T., & Ades, P. A. (2003) · American Heart Journal · doi:10.1016/s0002-8703(02)94706-x · Cited by 82
Depressive symptoms are associated with unhealthy lifestyles in hypertensive patients with the metabolic syndrome
Bonnet, F., Irving, K., Terra, J., Nony, P., Berthézène, F., & Moulin, P. (2005) · Journal of Hypertension · doi:10.1097/01.hjh.0000160219.71350.d2 · Cited by 82
A practical approach to risk assessment to prevent coronary artery disease and its complications
Linton, M. F., & Fazio, S. (2003) · The American Journal of Cardiology · doi:10.1016/s0002-9149(03)00505-8 · Cited by 83
Metabolic syndrome and inflammatory biomarkers: a community-based cross-sectional study at the Framingham Heart Study
Dallmeier, D., Larson, M. G., Vasan, R. S., Keaney, J. F., Fontes, J. D., Meigs, J. B., Fox, C. S., & Benjamin, E. J. (2012) · Diabetology & Metabolic Syndrome · doi:10.1186/1758-5996-4-28 · Cited by 83
Periodontal Status of Patients With Metabolic Syndrome Compared to Those Without Metabolic Syndrome
Khader, Y. S., Khassawneh, B. Y., Obeidat, B., Hammad, M., El‐Salem, K., Bawadi, H. A., & Al‐Akour, N. (2008) · Journal of Periodontology · doi:10.1902/jop.2008.080022 · Cited by 83
The effect of telmisartan on glucose and lipid metabolism in nondiabetic, insulin-resistant subjects
Nagel, J. M., Tietz, A. B., Göke, B., & Parhofer, K. G. (2006) · Metabolism · doi:10.1016/j.metabol.2006.04.011 · Cited by 83
Association of Metabolic Syndrome With Proximal and Synchronous Colorectal Neoplasm
Chiu, H., Lin, J., Shun, C., Liang, J., Lee, Y., Huang, S., & Wu, M. (2006) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2006.06.022 · Cited by 83
Metabolic changes associated with antipsychotic use.
Lieberman, J. A. (2004) · PubMed Central · Cited by 83
Central Adiposity Determines Prevalence Differences of the Metabolic Syndrome
Lorenzo, C., Serrano‐Ríos, M., Martínez‐Larrad, M. T., Gabriel, R., Williams, K., Gómez-Gerique, J. A., Stern, M. P., & Haffner, S. M. (2003) · Obesity Research · doi:10.1038/oby.2003.198 · Cited by 83
Safety and impact on cardiovascular events of long-term multifactorial treatment in patients with metabolic syndrome and abnormal liver function tests: a post hoc analysis of the randomised ATTEMPT study
Athyros, V. G., Γιουλεμέ, Ό., Ganotakis, E. S., Elisaf, M., Τζιόμαλος, Κ., Vassiliadis, T. G., Liberopoulos, E. N., Theocharidou, E., Karagiannis, A. I., & Mikhailidis, D. P. (2011) · Archives of Medical Science · doi:10.5114/aoms.2011.25554 · Cited by 82
Definition and early diagnosis of metabolic syndrome in children
Flemming, G. M. C., Bussler, S., Körner, A., & Kieß, W. (2020) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem-2019-0552 · Cited by 82

Authors: Isomaa, B., Almgren, P., Tuomi, T., Forsén, B., Lahti, K., Nissén, M., Taskinen, M.-R., & Groop, L.
Affiliations: Department of Internal Medicine, Jakobstad Hospital, Jakobstad, Finland
Lund University (SE)
Helsinki University Hospital (FI)
Närpes Health Center, Närpes
Vasa Health Center
Vaasa Central Hospital (FI)
ORCID: Almgren, Peter
Taskinen, Marja-Riitta
Groop, Leif
Venue: Diabetes Care
Publisher: American Diabetes Association
Published: 2001-04-01
Volume: 24
Issue: 4
Pages: 683-689
ISSN: 0149-5992 (ISSN-L)
1935-5548
DOI: 10.2337/diacare.24.4.683
OpenAlex: W1986349550
Cited by: 4,760
References: 36
Citations by year: 2026: 27 · 2025: 70 · 2024: 93 · 2023: 88 · 2022: 123 · 2021: 132 · 2020: 128 · 2019: 137 · 2018: 139 · 2017: 153 · 2016: 185 · 2015: 198 · 2014: 218 · 2013: 211 · 2012: 222
FWCI: 100.87
Type: journal article
Language: en
Open access: closed
Locations: Diabetes Care (publishedVersion)
PubMed (publishedVersion)
Lund University Publications (Lund University) (submittedVersion)
Funders: Svenska Läkaresällskapet
Topics: Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Function and Risk Factors
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Health and Risk Factors
Keywords: metabolic syndrome, cardiovascular mortality, cardiovascular morbidity, type 2 diabetes, impaired fasting glucose, impaired glucose tolerance, insulin resistance, microalbuminuria, coronary artery disease, stroke, obesity, hypertension, dyslipidemia, WHO definition
MeSH terms: Adult, Age Factors, Aged, Albuminuria, Blood Glucose, Cardiovascular Diseases, Cholesterol, Diabetes Mellitus, Type 2, Family, Female, Finland, Glycated Hemoglobin, Humans, Hyperlipidemias, Hypertension, Insulin Resistance, Cholesterol, HDL, Male, Middle Aged, Morbidity, Obesity, Risk Factors, Sex Factors, Sweden, Triglycerides, Prevalence, Glucose Intolerance

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Cardiovascular Morbidity and Mortality Associated With the Metabolic Syndrome

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks